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nistic understanding of cancer invasion and metastasis,
the contribution of the tumour microenvironment to meta-
static progression, and how invasion and the microenviron-
ment jointly support cancer cell survival and resistance.
Using organotypic models in vitro, live-cell imaging in
three-dimensional (3D) tissue culture has identified how
cytoskeletal, adhesion and protease systems drive invasion
and metastasis [1]. When altered at the molecular level,
these pathways underlie the unexpected diversity of the
invasive process [2]. The recent use of intravital microscopy
has further suggested that cancer invasion into interstitial
stroma in vivo: (1) occurs mostly as collective invasion in
which cells remain coupled to neighbouring cancer cells,
(2) is guided by and responsive to signals delivered by con-
nective tissue structures and (3) that invasion pathways
cross-talk with pathways of cancer cell survival and resis-
tance to anticancer therapy [3].
1. Principles of collective cell invasion
Collective cell migration is defined as the movement of multi-
ple cells that retain cell–cell contacts, coordinate their actin
dynamics and intracellular signaling, and thereby form a
structural and functional unit for joint translocation [1,4]. In
contrast to single-cell migration, moving cell masses remain
mechanically coupled by cell–cell adhesion receptors, most
notably of the cadherin and integrin families, and form a
coordinated cortical structure of the actin cytoskeleton, occa-
sionally referred to as a ‘super-cell’ [4]. Besides cancer inva-
sion and metastasis, collective cell movement contributes to
cell migration in morphogenesis and tissue repair [5], sug-
gesting homologous underlying mechanisms.
As in all known types of actomyosin-based cell migration,
collective migration is plastic, i.e. it undergoes modification
with altered intracellular signaling or an altered environment[2]. Interference with molecules that maintain or regulate
collective cell behaviour can lead to single-cell detachment.
Depending on the type of single-cell migration obtained after
dissociation, two types of conversion are currently known:
the epithelial–mesenchymal transition (EMT) and the collec-
tive–amoeboid transition (CAT). EMT is a well established
molecular process that leads to the down modulation of
cell–cell adhesion, whereby the migration machinery remains
intact, which induces cell detachment and scattering from
multicellular groups [1] (and references therein). Mechanisms
that enable single-cell detachment include reduced cadherin
expression, loss-of-function mutations in cadherin and cate-
nin [mit Leerzeichen ersetzen] signaling pathways, and
deregulated function of proteases degrading cadherins and
other cell–cell adhesion molecules [4]. In vivo, EMT corre-
sponds to the loss of differentiated epithelial morphology in
usually small regions towards a sarcomatous, stromal and,
hence, invasive and likely metastatic phenotype. CAT is the
transition from collective invasion to amoeboid single-cell
crawling after simultaneous weakening of cell–cell and cell–
ECM interactions, such as after EMT-independent down-regu-
lation of cadherins (data not shown) or inhibition of b1 inte-
grins in collectively invading melanoma explants [5] and in
tumour xenografts in vivo (data not shown). Detached cells
then survive, continue to move via amoeboid shape change
(similarly to interstitial migration of amoeboid leukocytes
[6]), and eventually cause distant metastasis (S. Alexander,
MD Anderson Cancer Center). These findings suggest that
collective migration represents an invasion mode of high cel-
lular and molecular order that, after loss of function of partic-
ular adhesion pathways, interconverts to single-cell
dissemination and metastasis. The understanding of the sig-
nals maintained by simultaneous cell–cell and cell–matrix
communication during collective invasion and secondary
plasticity will be important in defining the cross-talk between
strategies of invasion and resistance signaling [3].egen, The
Fig. 1 – Signaling pathways controlling tumour cell growth, survival and invasion. Example pathways of p53, Ras GTPase,
small Rho GTPases, integrins, growth factor receptors and cadherins with a dual role in controlling cell growth (upper row)
and survival as well as cell migration and invasion (lower row). Migration effectors are marked in pink, survival effectors in
purple, signaling hubs in bright green. Arrows indicate signaling direction. Bound to DNA, transcription factors. Figure taken
from Ref. [3]. a-Act., a-actinin; cat, catenin; Cdc42, cell division cycle 42; CREB, cAMP response element-binding; CyclD1, cyclin
D1; eIF, eukaryotic initiation factor; ERK, extracellular signal-related kinase; ETS, erythroblast transformation specific
(transcription factor); FAK, focal adhesion kinase; GEF, guanine nucleotide exchange factor; GFR, growth factor receptor; GRB2,
growth factor receptor-bound protein 2; ILK, integrin-linked kinase; Integ., integrin; JNK, Janus-kinase; MEK, mitogen-
activated protein kinase/extracellular signal-regulated kinase kinase; MEKK, MEK kinase; mTOR, mammalian target of
rapamycin; MLC, myosin light chain; MLCPtase, MLC phosphatase; MRCK, myotonic dystrophy kinase-related Cdc42-binding
kinase; NFjB, nuclear factor ‘kappa-light-chain-enhance’ of activated B cells; PAK, p21-activated kinase; PINCH, particularly
interesting Cys–His-rich protein; PKC, protein kinase C; PLCc, phospholipase c; PI3K, phosphoinosid-3-kinase; PTEN,
phosphatase and tensin homologue; ROCK, Rho-activated kinase; STAT, signal tranducer and activator of transcription;
TIAM1, T-cell lymphoma invasion and metastasis 1; Vinc, vinculin; WASP, Wiskott–Aldrich syndrome protein; WAVE; WASP
family Verprolin-homologous protein. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
292 E J C S U P P L E M E N T S 1 1 ( 2 0 1 3 ) 2 9 1 –2 9 32. Intravital multiphoton microscopy of
collective cancer invasion in vivo
Multiphoton microscopy (MPM) has become the method of
choice for investigating cell structure and function in tissues
and organs, including the invasion and progression of cancer
lesions [7]. Particularly suited for cancer research is infrared
multiphoton microscopy, which enables deep tissue penetra-
tion and detects multicellular, collective invasion of mela-
noma and soft-tissue sarcoma lesions in vivo [8]. Recent
evidence from intravital microscopy further suggests that col-
lective invasion is strongly associated with resistance to radi-
ation therapy and chemotherapy.3. Joint mechanisms of cancer invasion and
resistance
Based on the multiple inputs from the tumour microenviron-
ment and their overlapping signaling pathways, invasive tu-
mour-cell migration and resistance are now considered as
interconnected cell functions. To gain deeper insight into
the steps and niches of concurrent resistance and dissemina-
tion, preclinical animal models followed by time- and space-
resolved molecular imaging are necessary to detect tumour
responses to therapy at a cellular level. The signals required
for both single-cell and collective cancer invasion include
the activation of integrins, cadherins, small GTPases Rac
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intracellular signaling networks that include PI3K, mTOR,
Src and Map kinases (Fig. 1). Consequently, druggable signal-
ing hubs that may serve to target both tumour invasion and
resistance include growth factor and chemokine signaling,
integrin engagement, as well as downstream Ras/MAPKs,
PI3K and mTOR signaling. Thereby, the residual niches that
withstand targeting of conventional therapy can consist of a
limited number of cells which, after surviving cycles of thera-
pies, regrow, initiate migration and thereby re-establish an
invasive tumour.
4. Outlook
Collective invasion types contribute and provide particular
challenges to the progression and therapy of cancer disease.
The cell mass likely produces high autocrine concentrations
of promigratory factors and matrix proteases. Because many
cells move as one functional unit, cells of different clonal ori-
gin or different biological abilities may be linked and invade
together (‘mixed clone’ behaviour). Furthermore, it can pro-
tect inner cells from immunological assault through cytotoxic
lymphocytes. As a particular challenge, the joint signaling
from tissue structures and cell–cell junctions may activate
survival pathways not engaged in quiescent, non-invading tu-
mour regions. Thus, preclinical in vivomicroscopy will enable
both fascinating insight into the basic mechanisms of cancer
biology as well as advance preclinical validation of drugs and
the identification of resistance mechanisms.Conflict of interest statement
None declared.R E F E R E N C E S[1] Friedl P, Alexander S. Cancer invasion and the
microenvironment: plasticity and reciprocity. Cell
2011;147:992–1009.
[2] Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning
model. J Cell Biol 2010;188:11–9.
[3] Alexander S, Friedl P. Cancer invasion and resistance:
interconnected processes of disease progression and therapy
failure. Trends Mol Med 2012;18:13–26.
[4] Friedl P, Locker J, Sahai E, Segall JE. Classifying collective
cancer cell invasion. Nat Cell Biol 2012;14:777–83.
[5] Friedl P, Gilmour D. Collective cell migration in
morphogenesis, regeneration and cancer. Nat Rev Mol Cell
Biol 2009;10:445–57.
[6] Hegerfeldt Y, Tusch M, Brocker EB, Friedl P. Collective cell
movement in primary melanoma explants: plasticity of cell–
cell interaction, beta1-integrin function, and migration
strategies. Cancer Res 2002;62:2125–30.
[7] Andresen V, Alexander S, Heupel W-M, et al. Infrared
multiphoton microscopy: subcellular-resolved deep tissue
imaging. Curr Opin Biotechnol 2009;20:54–62.
[8] Alexander S, Koehl GE, Hirschberg M, Geissler EK, Friedl P.
Dynamic imaging of cancer growth and invasion: a modified
skin-fold chamber model. Histochem Cell Biol
2008;130:1147–54.
